Literature DB >> 17456779

Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.

Yoh Zen1, Takahiko Fujii, Seiichi Yoshikawa, Hiroyuki Takamura, Takashi Tani, Tetsuo Ohta, Yasuni Nakanuma.   

Abstract

In this study, we examined the possible involvement of progenitor cells in the carcinogenesis of human hepatocellular carcinoma (HCC) using tissue specimens and cell lines. We used ATP-binding cassette transporter ABCG2 as a progenitor cell marker. Immunohistochemically, ABCG2(+) hepatocytes were observed in the periportal areas of the dysplastic nodule, and ABCG2(+) cancer cells were also scattered or focally clustered in HCC. We sorted the cultured HCC cells (HuH7 and PLC5) into ABCG2(+) and ABCG2(-) subpopulations and then subcultured them for 4 weeks. ABCG2(+) cells could generate ABCG2(+) and ABCG2(-) progenies during subculture, whereas ABCG2(-) cells bore only ABCG2(-) cells, suggesting that a cancer cell hierarchy with reference to ABCG2 exists in HCC cells and that ABCG2(+) cells reside at the higher rank in that hierarchy. Interestingly, other progenitor cell markers including cytokeratin 19 and alpha-fetoprotein were mainly expressed in ABCG2(+) subpopulations. Conversely, albumin expression was more intense in ABCG2(-) cells. In addition, the expression patterns of transcription factors (GATA6, CCAAT/enhancer-binding protein alpha, and CCAAT/enhancer-binding protein beta) in ABCG2(+) and ABCG2(-) cells resembled those during normal liver development. In conclusion, this study suggests that cancer cells with ABCG2 expression might play a central role in hepatocarcinogenesis and the maintenance of the cancer cell hierarchy of human HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456779      PMCID: PMC1854968          DOI: 10.2353/ajpath.2007.060798

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo.

Authors:  Sheng Zhou; John J Morris; Yuxiao Barnes; Lubin Lan; John D Schuetz; Brian P Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

Review 2.  Heterogeneity and plasticity of hepatocyte lineage cells.

Authors:  S Sell
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  The canals of Hering and hepatic stem cells in humans.

Authors:  N D Theise; R Saxena; B C Portmann; S N Thung; H Yee; L Chiriboga; A Kumar; J M Crawford
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.

Authors:  S Zhou; J D Schuetz; K D Bunting; A M Colapietro; J Sampath; J J Morris; I Lagutina; G C Grosveld; M Osawa; H Nakauchi; B P Sorrentino
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

7.  Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences.

Authors:  Sara Vander Borght; Louis Libbrecht; Aezam Katoonizadeh; Jos van Pelt; David Cassiman; Frederik Nevens; Alfons Van Lommel; Bryon E Petersen; Johan Fevery; Peter L Jansen; Tania A Roskams
Journal:  J Histochem Cytochem       Date:  2006-05-18       Impact factor: 2.479

8.  Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.

Authors:  Bryan E Welm; Stacey B Tepera; Teresa Venezia; Timothy A Graubert; Jeffrey M Rosen; Margaret A Goodell
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

9.  The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.

Authors:  David Cassiman; Louis Libbrecht; Nicoletta Sinelli; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter.

Authors:  Andreas Lechner; Colin A Leech; Elizabeth J Abraham; Anna L Nolan; Joel F Habener
Journal:  Biochem Biophys Res Commun       Date:  2002-05-03       Impact factor: 3.575

View more
  32 in total

1.  Characterization of CD133+ parenchymal cells in the liver: histology and culture.

Authors:  Seiichi Yoshikawa; Yoh Zen; Takahiko Fujii; Yasunori Sato; Tetsuo Ohta; Yutaka Aoyagi; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

2.  Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.

Authors:  Yang Jiang; Yan He; Hui Li; Hui-Ning Li; Lei Zhang; Wei Hu; Ya-Meng Sun; Fu-Lai Chen; Xiao-Ming Jin
Journal:  Gastric Cancer       Date:  2012-02-14       Impact factor: 7.370

3.  Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.

Authors:  Caecilia Hc Sukowati; Natalia Rosso; Lory S Crocè; Claudio Tiribelli
Journal:  World J Hepatol       Date:  2010-03-27

Review 4.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma.

Authors:  Junfang Ji; Xin Wei Wang
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

Review 5.  Research progress and prospects of markers for liver cancer stem cells.

Authors:  Cheng-Pei Zhu; An-Qiang Wang; Hao-Hai Zhang; Xue-Shuai Wan; Xiao-Bo Yang; Shu-Guang Chen; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 6.  Liver cancer stem cells.

Authors:  Stewart Sell; Hyam L Leffert
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

7.  Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials.

Authors:  Guo-Ming Shi; Yang Xu; Jia Fan; Jian Zhou; Xin-Rong Yang; Shuang-Jian Qiu; Yong Liao; Wei-Zhong Wu; Yuan Ji; Ai-Wu Ke; Zhen-Bin Ding; Yi-Zhou He; Bing Wu; Guo-Huan Yang; Wen-Zhen Qin; Wu Zhang; Jiang Zhu; Zhi-Hui Min; Zhi-Quan Wu
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-10       Impact factor: 4.553

8.  Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods.

Authors:  Gang Shen; Fang Shen; Zhuojin Shi; Weiguo Liu; Weiwei Hu; Xuesheng Zheng; Liang Wen; Xiaofeng Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-07-02       Impact factor: 2.416

Review 9.  Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.

Authors:  Stewart Sell
Journal:  Tumour Biol       Date:  2008-07-09

10.  Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.

Authors:  Sheng-Dong Huang; Yang Yuan; Xiao-Hong Liu; De-Jun Gong; Chen-Guang Bai; Feng Wang; Jun-Hui Luo; Zhi-Yun Xu
Journal:  BMC Cancer       Date:  2009-01-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.